Navigation Links
QualityStar Presenting at Biomarkers & Diagnostics World Congress
Date:2/28/2013

Omaha, NE (PRWEB) February 28, 2013

QualityStar will present a new application utilizing whole slide digital imaging (WSI) for anatomic pathology external peer review quality assurance. The presentation will review current quality assurance programs and the application of WSI as a novel approach to gain longitudinal benchmarking data for quality review. Healthcare institutions, pathologists and payers will find the information provided valuable in reviewing their current quality programs and continuous improvement initiatives to reduce error in cancer diagnoses.

Mark Priebe of QualityStar commented, “We are focused on the continuous improvement in cancer diagnosis. We are looking forward to sharing with the Congress our unique quality assurance program for anatomic pathology.”

The Cambridge Healthtech Institute’s Ninth Annual Biomarkers & Diagnostics World Congress will be held May 6 through May 8, 2013, in Philadelphia, PA.

About Cambridge Healthtech:
Cambridge Healthtech is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The May meeting brings together a mix of pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers fostering collaborations across industry and academia, to evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations, brainstorming sessions for decision makers. It is the leading annual meeting dedicated to biomarker and diagnostics research implementation.

About QualityStar:
QualityStar offers a unique opportunity to the healthcare community by providing a reliable, high-quality alternative to in-house quality assurance for healthcare professionals. With a national network of consultant reviewers to deliver third party quality assurance, QualityStar becomes a partner in the individual’s or institution’s quality efforts. QualityStar ensures pathologists’ and laboratory professionals’ work is reviewed based on a quality plan and provides longitudinal and benchmarking reports that go beyond standard peer review.

Read the full story at http://www.prweb.com/releases/QualityStar/Philadelphia/prweb10480474.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
2. Chembio Presenting at Biotech Conference
3. Amarantus BioScience and Banyan Biomarkers to Present Poster of MANF Data at The 3rd Annual Traumatic Brain Injury Conference
4. Astute Medical, Inc. Advancing Next Generation Acute Kidney Injury Biomarkers
5. Caris Life Sciences Enhances Molecular Profiling Service with Addition of ROS1 and MGMT-Methylation Biomarkers
6. Biomarkers: Technological and Commercial Outlook 2012-2022
7. Australian Discovered Biomarkers Map Path to New Blood Test for Bowel Cancer
8. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
9. MarketsandMarkets: Global Biomarkers Market worth $25.79 Billion by 2016
10. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
11. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):